Another study showed that the increase of fecal eslastase-1 and the decrease of serum IRT were maintained for an additional 84 weeks in CF children with a CFTR gating-mutation treated with Ivacaftor, suggesting that early CFTR modulation can potentially delay the decline of pancreatic function (18). The gene discussed is CFTR; the disease is cystic fibrosis.